{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:45:02Z","timestamp":1759099502231,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ahj.2009.02.001","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T10:15:19Z","timestamp":1237803319000},"page":"908-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study"],"prefix":"10.1016","volume":"157","author":[{"given":"Jung-Won","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shik","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pum-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Bae","family":"Seung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2009.02.001_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1657526","article-title":"Tissue factor in the pathogenesis of atherosclerosis","volume":"78","author":"Taubman","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2009.02.001_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.thromres.2007.04.013","article-title":"Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: correlation with the severity of atheromatosis","volume":"121","author":"Lima","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.ahj.2009.02.001_bib3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.CIR.0000091082.75419.9F","article-title":"Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation","volume":"108","author":"Tutar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.02.001_bib4","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jacc.2004.07.028","article-title":"Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system","volume":"44","author":"Palmerini","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.02.001_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0008-6363(01)00452-7","article-title":"Tissue factor and coronary artery disease","volume":"53","author":"Moons","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2009.02.001_bib6","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/CIRCULATIONAHA.105.617167","article-title":"Vitamin K epoxide reductase complex and vascular calcifications: is this the important link between vitamin K and the arterial vessel wall?","volume":"113","author":"Spronk","year":"2006","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2009.02.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2007.02549.x","article-title":"VKORC1: molecular target of coumarins","volume":"5","author":"Oldenburg","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2009.02.001_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2004-06-2111","article-title":"A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin","volume":"105","author":"D'Andrea","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ahj.2009.02.001_bib9","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa044503","article-title":"Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose","volume":"352","author":"Rieder","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2009.02.001_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0708078","article-title":"Genetic determinants of response to warfarin during initial anticoagulation","volume":"358","author":"Schwarz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2009.02.001_bib11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.105.580167","article-title":"VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection)","volume":"113","author":"Wang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.02.001_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/ATVBAHA.107.159913","article-title":"Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification. The Rotterdam Study","volume":"28","author":"Teichert","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2009.02.001_bib13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/ng1558","article-title":"Toward genome-wide SNP genotyping","volume":"37","author":"Syv\u00e4nen","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ahj.2009.02.001_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ng1547","article-title":"A genome-wide scalable SNP genotyping assay using microarray technology","volume":"37","author":"Gunderson","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ahj.2009.02.001_bib15","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000030314.11999.6A","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.02.001_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.02.001_bib17","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/j.1538-7836.2007.02705.x","article-title":"Common VKORC1 variants are not associated with arterial or venous thrombosis","volume":"5","author":"Hindorff","year":"2007","journal-title":"J Thormb Haemost"},{"key":"10.1016\/j.ahj.2009.02.001_bib18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.02.001_bib19","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.105.569129","article-title":"Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design","volume":"112","author":"Steffel","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.02.001_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.RES.0000233379.92010.fd","article-title":"Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation","volume":"99","author":"St\u00e4hli","year":"2006","journal-title":"Cir Res"},{"key":"10.1016\/j.ahj.2009.02.001_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"L\u00fcscher","year":"2007","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309001021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309001021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:38:23Z","timestamp":1757569103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870309001021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0002870309001021"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2009.02.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2009.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}